Literature DB >> 22973339

Relationship between echocardiographic findings and laboratory serum biomarkers in patients with and without low cardiac output.

Mohammad Reza Khalilian1, Mohammad Reza Sabri, Abdolrasoul Nikyar, Shaghayegh Haghjooy Javanmard.   

Abstract

BACKGROUND: Cardiac dysfunction is seen in many patients and could be evaluated with echocardiography and serum biomarkers. The aim of this study was evaluation of the relationship between echocardiographic findings and laboratory serum biomarkers in children with and without low cardiac output.
METHODS: Thirty patients older than 1 month with and without low cardiac output were enrolled in this study. It composed of 13 patients with dilated cardiomyopathy (DCM), 7 with end stage renal disease (ESRD) and 10 who had a Fontan operation. Echocardiography was performed with emphasis on shortening fraction (SF) and ejection fraction (EF). Blood samples were collected for measurement of atrial natriuretic peptide (ANP), high sensitivity C-reactive protein (hs-CRP) and alkaline phosphatase (Alk-P). Both echocardiographic findings and laboratory data were compared with control levels in twenty-seven normal children. Pearson correlation and regression analysis were conducted to evaluate the aforementioned associations.
RESULTS: The mean of ANP and hs-CRP in the case group was statistically higher than control group (p < 0.001). The mean of ANP and hs-CRP were different in all groups (p < 0.001). There was a reverse linear regression between the SF and ANP in the case group (r = -0.594, p < 0.001).
CONCLUSIONS: Determination of the plasma ANP and hs-CRP level may be helpful for decisions related to early diagnosis of patient with low cardiac output.

Entities:  

Keywords:  Atrial Natriuretic Peptide; Ejection Fraction; High Sensitivity C-reactive Protein; Shortening Fraction

Year:  2011        PMID: 22973339      PMCID: PMC3430055     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


  19 in total

1.  Cardiac physiopathology and alkaline phosphatase.

Authors:  Maria João Martins; Isabel Azevedo
Journal:  Pediatr Cardiol       Date:  2008-12-02       Impact factor: 1.655

2.  Atrial natriuretic peptide: could it be a marker for postoperative recurrent effusions after Fontan circulation in complex congenital heart defects?

Authors:  T Alkan; A Sarioğlu; U B Samanli; T Sarioğlu; A Akçevin; H Türkoğlu; T Paker; A Aytaç
Journal:  ASAIO J       Date:  2006 Sep-Oct       Impact factor: 2.872

3.  Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass.

Authors:  M Chello; P Mastroroberto; F Perticone; F Cirillo; E Bevacqua; S Olivito; E Covino
Journal:  Eur J Cardiothorac Surg       Date:  2001-07       Impact factor: 4.191

4.  Cytokine profile in chronic cardiac failure.

Authors:  I C Steele; A M Nugent; S Maguire; M Hoper; G Campbell; M I Halliday; D P Nicholls
Journal:  Eur J Clin Invest       Date:  1996-11       Impact factor: 4.686

5.  Serum alkaline phosphatase reflects post-Fontan hemodynamics in children.

Authors:  Alvin J Chin; P Stephens; E Goldmuntz; M B Leonard
Journal:  Pediatr Cardiol       Date:  2008-08-07       Impact factor: 1.655

6.  N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.

Authors:  Rowan Walsh; Clark Boyer; Jared LaCorte; Vincent Parnell; Cristina Sison; Devyani Chowdhury; Kaie Ojamaa
Journal:  J Thorac Cardiovasc Surg       Date:  2008-01       Impact factor: 5.209

7.  Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I.

Authors:  Fabio Carmona; Paulo H Manso; Walter V A Vicente; Margaret Castro; Ana P C P Carlotti
Journal:  Cytokine       Date:  2008-04-15       Impact factor: 3.861

8.  Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy.

Authors:  A Westerlind; H Wåhlander; G Lindstedt; P A Lundberg; D Holmgren
Journal:  Acta Paediatr       Date:  2004-03       Impact factor: 2.299

9.  The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure.

Authors:  A I Larsen; K Dickstein; N S Ahmadi; T Aarsland; J T Kvaløy; C Hall
Journal:  Eur J Heart Fail       Date:  2006-02-07       Impact factor: 15.534

Review 10.  Role of C-reactive protein in cardiovascular disease.

Authors:  James M Backes; Patricia A Howard; Patrick M Moriarty
Journal:  Ann Pharmacother       Date:  2004-01       Impact factor: 3.154

View more
  1 in total

1.  Can atrial natriuretic peptides measurement diagnose heart failure at different age groups?

Authors:  Allahyar Golabchi
Journal:  J Res Med Sci       Date:  2012-01       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.